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AbsTRACT
background One of the most widely available heated 
tobacco products is IQOS by Philip Morris International. 
However, there is a lack of independent research 
exploring IQOS initiation and subsequent use among 
smokers and ex- smokers.
Aims To (1) explore the reasons why smokers and 
ex- smokers use and continue/discontinue IQOS and (2) 
consider implications for future research and policy.
Participants Adult (18+) current (n=22) and ex- users 
(n=8) of IQOS who either currently smoked or quit 
smoking in the last 2 years.
Methods Qualitative interview study in London, UK.
Results Six main factors influenced initiation and use 
of IQOS: (1) Health—wanting to reduce/quit smoking 
and perceptions of reduced harm (while understanding 
IQOS was not risk- free). Branded packaging, absence 
of pictorial warnings and physical health improvements 
conveyed reduced harm. (2) Financial—including 
high start- up costs, but cheaper ongoing costs than 
smoking. (3) Physical—mixed views on enjoyment 
and satisfaction. Sensory experiences influenced use 
including discreetness, cleanliness, reduced smell and 
tactile similarities relative to combustible cigarettes. (4) 
Practical—issues of accessibility, shortcomings with 
maintenance/operation limited ongoing use, whereas use 
in smoke- free places increased use. (5) Psychological—
similarities in rituals and routines, although new practices 
developed to charge and clean; some liked trailblazing 
new technology. (6) Social—improved social interactions 
from using IQOS instead of smoking, but with more 
limited shared social experiences for some.
Conclusion For some, IQOS facilitated smoking 
substitution. Factors such as packaging, labelling, risk 
communication, price and smoke- free policies appear to 
influence initiation and use.
InTRoduCTIon
The IQOS battery- powered heated tobacco product 
(HTP) by Philip Morris International (PMI) was 
launched in 20141 2 (figure 1). PMI claims that 
IQOS heats rather burns tobacco sticks (branded 
HEETS), thus avoiding burning and emitting “95% 
lower levels of harmful chemicals compared with 
cigarettes”.3 4 Available in over 40 countries, PMI 
estimate that 6.6 million smokers have quit smoking 
and switched to IQOS.5
Since the 2016 UK launch of IQOS, sale loca-
tions have expanded beyond official IQOS stores 
to other retailers.6 7 Prevalence of IQOS use in the 
UK is uncertain. One study estimated overall HTP 
use at 0.82%; however, the measure used may have 
been problematic.8 IQOS advertising appears in the 
UK, but HEETS advertising does not. IQOS retails 
between £59 and £89; HEETS retailed at £8 for 
a packet of 20 until July 2019 when PMI reduced 
the price to £5, less than half that of most combus-
tible cigarettes.9–11 HEETS are not subject to stan-
dardised packaging and pictorial warnings, and 
only require a 30% black- and- white text warning 
(figure 2). There are no official policies on using 
IQOS in public.
In April 2019, the US Food and Drug Administra-
tion (FDA) authorised IQOS and ‘Heat Sticks’ for 
marketing in the USA.12 Research (mostly tobacco 
industry funded) suggests that, compared with 
combustible cigarettes, there are reduced toxins in 
the aerosol produced by IQOS; IQOS may reduce 
users’ exposure to some “harmful and potentially 
harmful constituents”; and some biomarkers of 
harm may be reduced when switching from smoking 
combustible cigarettes to IQOS.13–20 However, the 
public health impact of IQOS will depend on the 
degree to which use is less harmful than smoking, 
whether smokers switch completely to IQOS, and 
the extent of non- smoker uptake.17 21
Most research on consumer responses to IQOS 
has been conducted by PMI.22–25 Independent 
survey research found that IQOS is perceived as 
less harmful than smoking.26–28 Focus group studies 
in Switzerland and Japan found IQOS was more 
socially acceptable, cleaner and uptake was encour-
aged by ‘clean and chic’ marketing and less of a harsh 
feeling on the throat compared with cigarettes.29 
However, the bulkiness of the device, charging/
cleaning, cost and the odd smell discouraged use.29 
Popular reasons for using IQOS identified in a Swiss 
study included complete smoking cessation, the 
reduced toxicity relative to smoking, the reduced 
smell and the improved taste.28 Most users found 
IQOS weaker on the throat than combustible ciga-
rettes and reported improved physical health, but 
feared becoming dependent.28
Due to increased availability of IQOS, its use for 
harm reduction and its rapid uptake in some coun-
tries,30 it is crucial that we develop a better under-
standing of smokers’ perceptions and responses 
to IQOS. Thus, we conducted a qualitative study 
with IQOS users and ex- users in London to explore 
and understand the factors that encourage and 
discourage current and ex- smokers to initiate, 
continue, and discontinue IQOS use. We used inter-
views to explore individuals’ experiences in detail 
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Figure 1 IQOS 2.4 Plus and HEETS tobacco sticks. Figure 2 HEETS tobacco sticks and combustible cigarette packaging 
in the UK.
and to obtain a greater depth of data than could be generated 
from focus groups.
MeThods
Eligibility criteria were adults (18+) who (1) currently smoked 
or quit smoking in the last 2 years, (2) use or used IQOS at least 
weekly for at least 1 month, and (3) lived in the UK. We recruited 
online (research recruitment website, classifieds, social media) 
and via a university- wide email. Posters were also displayed in 
vape shops selling IQOS across London and we approached 
individuals using IQOS in public. After screening, eligible indi-
viduals were selected for interview based on their demographics 
and smoking/IQOS histories.
Between October 2018 and February 2019, CNET, a quali-
tative researcher and joint lead author, interviewed 30 people 
(28 face- to- face, 2 by telephone). A semistructured topic guide, 
informed by consultations with seven tobacco/nicotine experts 
and a panel of 12 current and ex- smokers, guided the inter-
views. It covered participants’ smoking history, motivations and 
experiences of using IQOS (including reasons for continued and 
discontinued use), the benefits and drawbacks of IQOS, and 
the perceived impacts of IQOS (overall and on their smoking). 
Participants were offered a £20 shopping voucher. Interviews 
lasted 36–102 min (mean=67).
Iterative categorisation, a rigorous and transparent approach, 
guided data coding and analyses.31 The authors read transcripts 
to familiarise themselves with the data, discussed the content, and 
developed a coding frame of deductive (based on areas included 
in the topic guide) and inductive (based on additional areas that 
arose during the interviews) thematic codes. The transcripts 
and the coding frame were imported into MaxQDA; CNET 
systematically coded each transcript and assigned all text to the 
relevant code/s. Then, AMcN, SCH and CNET jointly reviewed 
the coded data relating to why participants initiated, continued, 
and discontinued IQOS more inductively. They consolidated and 
re- organised the codes into health, financial, physical, practical, 
psychological and social factors. During analysis, the similarities 
and differences between participants were explored. Key find-
ings are illustrated using pseudonymised verbatim quotations.
FIndIngs
sample
Participants included n=22 current and n=8 ex- IQOS users, all 
UK residents from a variety of nationalities (table 1). Many had 
smoked or used nicotine products for 20+ years; most had tried 
e- cigarettes (table 2 and online supplementary tables 1–3). All 
currently used or had used IQOS 2.4 Plus.
Although we recruited smokers and ex- smokers, the interviews 
highlighted that smoking, IQOS and e- cigarette status was more 
complex. For example, some people identified as ex- smokers 
but when interviewed described recent situations where they 
smoked combustible cigarettes. Consequently, the quotations 
from people who said they no longer smoked at all (ex- smokers) 
are labelled as ‘former smoking’ to reflect that they have former 
experience of smoking but are not necessarily ex- smokers.
health factors
Smoking goal
Commonly, participants said that they experimented with IQOS 
because their goal was to reduce or stop smoking combustible 
cigarettes due to health risks. They thought that IQOS potentially 
Protected by copyright.
 o
n
 January 28, 2020 at King's College London.
http://tobaccocontrol.bmj.com/
Tob Control: first published as 10.1136/tobaccocontrol-2019-055306 on 15 January 2020. Downloaded from
 
3Tompkins CNE, et al. Tob Control 2020;0:1–8. doi:10.1136/tobaccocontrol-2019-055306
Research paper
Table 1 Demographic characteristics (n=30)
demographic
ex- IQos use
Current IQos 
use Total
(n=8) (n=22) (n=30)
Age (years)
  18–24 4 3 7
  25–34 1 7 8
  35–49 3 9 12
  50–59 0 3 3
Total age range 18–48 22–59 18–59
Median 25 36.5 32.5
Mean 28.6 36.7 34.6
Gender
  Male 4 15 19
  Female 4 7 11
Ethnicity
  White British 2 6 8
  White Other* 5 12 17
  Asian/Asian British† 0 3 3
  Black/Black British‡ 1 0 1
  Arabic 0 1 1
Occupation
  Professional/qualified work 2 7 9
  Managerial/senior 
administrator
2 7 9
  Clerical/junior administrator 2 6 8
  Sales/services 0 1 1
  Semi- skilled/unskilled labour 1 0 1
  Never worked 1 1 2
Current working status
  Full time (30+ hours) 2 18 20
  Part- time 2 1 3
  Currently unemployed 1 0 1
  Part- time student, part- time 
employment
2 2 4
  Full- time student 1 1 2
*These included 1 Australian, 3 Bulgarians, 1 German, 1 Irish, 3 Italians, 1 
Lithuanian, 1 Northern Irish, 2 Portuguese, 1 Russian, 1 Swiss, 1 Turkish and 1 
Ukrainian.
†These included 2 Indian British and 1 Sri Lankan British.
‡This participant was Black British.
Table 2 Overview of participants’ use of IQOS, combustible 
cigarettes and e- cigarettes (n=30)
ex- IQos use
(n=8)
Current IQos 
use
(n=22)
Total
(n=30)
First tried IQOS
  1–3 months ago 0 3 3
  4–6 months ago 0 3 3
  7–12 months ago 3 8 11
  More than 12 months 
ago
5 8 13
Length of IQOS use
  1–3 months 1 3 4
  4–6 months 3 4 7
  7–12 months 1 10 11
  More than 12 months 3 5 8
Country/region first tried 
IQOS
  UK 6 15 21
  Continental Europe* 2 5 7
  Japan 0 1 1
  South Africa 1 0 1
Cigarette smoking status
  Daily 4 3 7
  Weekly 0 4 4
  Monthly 1 3 4
  Less than monthly 1 5 6
  Not at all 2 7 9
E- cigarette use status
  Daily 1 1 2
  Weekly 0 0 0
  Monthly 1 0 1
  Less than monthly 0 1 1
  Ex- e- cigarette use† 5 19 24
  Never e- cigarette use‡ 1 1 2
Time using tobacco and 
nicotine products (years)
  1–5 4 5 9
  6–10 0 5 5
  11–20 2 1 3
  More than 20 1 11 12
Total range (years) 1–22 2–40 1–40
  Median (years) 14 17 14
  Mean (years) 9.7 17.7 15.7
*These included Bulgaria, Italy, Lithuania, Switzerland and Ukraine.
†As defined by answering “How often do you currently use e- cigarettes?” as “Not 
at all” and answering “Have you ever previously used e- cigarettes?” as “Yes”.
‡As defined by answering “Have you ever previously used e- cigarettes?” as “No”.
§This includes use of other tobacco and nicotine products during this period (eg, 
shisha and cigars). One participant did not disclose this information in a specific 
enough way, so exists as missing data. N.B. This also excludes large periods of time 
(over 1 year) in which successful quit attempts were made (ie, these years were 
removed from the total time spent using tobacco/nicotine products).
provided a new and ‘healthier’ path away from cigarettes. Some 
explained this goal differently—with no intention of ‘giving up’ 
or ‘quitting’ altogether, they perceived IQOS offered an alterna-
tive way to carry on ‘smoking’. While these individuals started 
IQOS to continue smoking (using it instead of combustible ciga-
rettes), they hoped that their health would benefit by replacing 
combustible cigarettes with HEETS.
I thought well I don’t want to go on smoking so many cigarettes… 
this is not doing my health any good… I wanted to do something 
about it, and stopping didn’t seem to be a realistic option, so I 
wanted to try this (IQOS). (Clive, 59, current IQOS user, less 
than monthly smoking)
Smoking goals also contributed to ongoing IQOS use. 
Although some reported that they had successfully used IQOS 
to stop smoking combustible cigarettes, few had quit smoking 
both combustible cigarettes and HEETS altogether, as they used 
HEETS in place of, or alongside combustible cigarettes.
Perception of harm
Participants repeatedly reported that they tried IQOS because 
they believed it was ‘better’, ‘less harmful’, ‘less hazardous’ or 
‘less damaging’ for their health than combustible cigarettes. This 
view originated from the well- documented harms of combus-
tible cigarettes, claims participants had read on PMI marketing 
material about IQOS, and the HEETS packets. Participants 
commented that HEETS packets were ‘cleaner’ than combustible 
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cigarettes as they had ‘less alarming’ written health warnings and 
did not contain graphic pictorial warnings.
I looked into IQOS and it did claim that it had… fewer harmful 
chemicals than a regular cigarette… That was part of the appeal. 
And I think that’s how it was marketed to me, that it was less 
harmful. (Alison, 35, ex- IQOS user, former smoking)
Believing IQOS was less harmful than smoking combustible 
cigarettes motivated continued use, often prompting participants 
to use up to twice as many HEETS as combustible cigarettes, and 
discouraging quitting IQOS.
Smoking cigarettes, I knew I was doing something really, really 
bad, and that I should… stop… whereas with this (IQOS), because 
I don’t know that it’s so bad for me, there really is no input or 
drive or motivation for me to think, ‘stop!’ (Francesca, 46, current 
IQOS user, former smoking)
At the same time, participants said that their mistrust of the 
tobacco industry and the ‘lack’ of independent evidence created 
uncertainty about the potential harms of IQOS. These issues 
did not discourage participants from trying IQOS but prompted 
them to seek more information and to consider their ongoing 
use. A few participants who found reports which contradicted 
claims of reduced harm debated discontinuing IQOS to return 
to combustible cigarettes.
I read a recent systematic review saying that IQOS is as harmful 
as cigarettes! So I thought well I might as well smoke cigarettes 
and not the IQOS. (Yasmina, 25, current IQOS user, weekly 
smoking)
Participants acknowledged that IQOS was unlikely to be risk- 
free because HEETS packets carried a warning and they had 
seen disclaimers on the PMI IQOS website and in IQOS stores. 
Furthermore, they perceived potential harms from ‘inhaling 
something’ into the lungs and from the tobacco, chemical and 
nicotine composition of HEETS. Nevertheless, they said that 
without detailed information about the ingredients and nicotine 
content of HEETS and in absence of longitudinal and indepen-
dent research into IQOS, they tried to remain optimistic about 
the harms of IQOS compared with combustible cigarettes. While 
participants believed that they would re- evaluate their IQOS use 
if evidence uncovered health risks, some questioned whether 
knowing the risks would influence their use given that they had 
not quit smoking combustible cigarettes despite knowing the 
harms.
Physical health indicators
Participants often reported that their physical health improved 
since they started using IQOS—they felt ‘fitter’ and more ener-
gised, had fewer breathing difficulties, noticed increased cardio-
vascular ability and coughed less. Such improvements reinforced 
their perceptions that IQOS was less harmful than combustible 
cigarettes and encouraged continued use.
I do find myself a bit less breathless, if I’m doing some exercise, or 
even walking up several flights of stairs, than I would have been… 
when I was smoking 10 cigarettes a day. Which… goes back to one 
of the reasons why I perceive it to be no more harmful, and if I’m 
honest probably slightly less harmful than cigarettes. (Sanjay, 43, 
current IQOS user, less than monthly smoking)
Conversely, no participants reported direct experience of 
adverse health consequences resulting in second thoughts about 
using IQOS or discontinuation of IQOS use.
Financial factors
Start-up and ongoing costs
Participants regularly expressed concerns that start- up costs 
of IQOS discouraged initiation. While free demos encouraged 
them to try IQOS, they felt that IQOS was ‘expensive’ and too 
costly compared with cigarettes or e- cigarettes to appeal to low- 
income smokers. To overcome financial barriers, some partic-
ipants received IQOS as a gift, purchased IQOS secondhand, 
or took advantage of promotions or more affordable prices in 
mainland Europe. Nevertheless, participants with fewer finan-
cial constraints considered that the price of IQOS, although 
‘not cheap’, was ‘worth it’ if it was ‘better’ than combustible 
cigarettes.
I thought it was worth me spending the £80, or whatever it was 
for the IQOS and a few free packets (of HEETS), even if it turned 
out not to be something I stuck to. (Raj, 43, current IQOS user, 
former smoking)
There were mixed views across participants on how the 
cost of IQOS influenced their continued use. A key driver for 
continuing to use IQOS was that HEETS were cheaper than 
combustible cigarettes, particularly when purchased in bulk via 
the PMI website or from countries with lower prices. Yet, partici-
pants who had previously smoked rolling tobacco or used e- ciga-
rettes complained that HEETS were less affordable. As such, cost 
discouraged continued IQOS use for those with limited finances.
A big factor (in stopping IQOS) was the cost… if I get it (HEETS) 
online… that will cost me a lot of money, and I have to be really 
careful with how I manage my money, because benefits (social 
security payments) only stretch so far. (Maria, 29, ex- IQOS user, 
daily smoking)
Physical factors
Enjoyment and satisfaction
Participants gave mixed accounts regarding how enjoyable and 
satisfying IQOS was. Reflecting on their first experiences, some 
commented that the similarity of the physical ‘kick’ of nicotine 
with smoking combustible cigarettes made IQOS enjoyable to 
use and easy to switch to. Others were ‘underwhelmed’ or ‘disap-
pointed’ by what they described as a ‘lighter’ and ‘less strong’ 
physical feeling but found that they grew accustomed to this 
with continued use, and rarely discontinued using IQOS because 
of it.
Generally, current users reported that the inhalation from 
IQOS felt ‘smoother’, ‘cleaner’, ‘less harsh’ and ‘lighter’ in their 
throats than that of combustible cigarettes. They described how 
this encouraged them to use IQOS and provided a ‘pleasant’ and 
‘enjoyable’ experience like smoking cigarettes but with fewer 
negative physical feelings in the throat.
I immediately thought yeah, this is like smoking… I get the same 
reward… It’s very similar to smoking because of that famous 
kick that you get… because I just use it in exactly the same way 
as I used a cigarette. (Francesca, 46, current IQOS user, former 
smoking)
Nevertheless, some remained uncertain about using IQOS. 
For example, they said that the experience was less satisfying 
than smoking combustible cigarettes on account of the lack of 
throat hit, the delivery of nicotine and the ‘too light’ flavour 
of the tobacco. These more variable experiences contributed to 
participants discontinuing IQOS or using cigarettes alongside 
IQOS.
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I got tired of it after a while… I wasn’t getting long- term… 
satisfaction from it, and I don’t think that my craving for cigarettes 
actually decreased as much as I would have liked it to… there 
wasn’t the same fulfilment. (Hayden, 48, ex- IQOS user, daily 
smoking)
Sensory experiences: sight, smell, taste and touch
The influence of IQOS on the senses of sight and smell regularly 
explained why participants experimented with IQOS. Partici-
pants were attracted to try IQOS due to its ‘slick’ and ‘stylish’ 
appearance, discreet size and high- quality finish, which differed 
to ‘bulky’, ‘huge’, ‘ugly’ tank- style e- cigarettes. The promise that 
IQOS created little smell also appealed to participants and stood 
in contrast with the ‘horrible’, ‘disgusting’ smell of combustible 
cigarettes and the ‘weird’, fruity odours of e- cigarettes.
(IQOS) is a nice piece of kit, very, very high quality, it looks very 
nice… It’s inoffensive, it’s not in anybody’s faces like… a great big 
vape kind of battery… it was very smart, very small, very stylish. 
(Neal, 47, current IQOS user, former smoking)
Participants commonly claimed that the overall sensory expe-
rience of using IQOS was equivalent to, or better than smoking 
combustible cigarettes, which accounted for continued use. They 
praised aspects of the sight (eg, the visual appeal of the branded 
HEETS packets, the ‘clearer’ and reduced volume of emissions, 
the lack of staining on fingers and teeth, and the cleanliness of 
no ash), smell (eg, the odourless nature of used HEETS and the 
lack of residual smell on hands, breath, clothes and furnishings), 
taste (eg, the comparable taste with combustible cigarettes and 
the lack of aftertaste) and touch (eg, the tactile feel of the device 
and the familiar circumference and texture of HEETS in the 
fingers and on the lips).
You can use IQOS and not feel bad about yourself afterwards in 
terms of like the aftertaste, the smell… you just feel nice. (Yulia, 
19, current IQOS user, less than monthly smoking)
Furthermore, participants who had smoked combustible ciga-
rettes after switching to IQOS described how the ‘dirty’, ‘smelly’ 
and ‘disgusting’ sensory experiences contrasted with ‘cleaner’ 
and ‘less messy’ use of IQOS. Consequently, participants often 
envisaged continuing to use IQOS even if the health- related 
harms were identified as equivalent to, or worse than smoking 
combustible cigarettes due to the overall ‘cleaner’ experience.
If there was a headline that says that IQOS was actually more 
harmful than cigarettes… I probably would still use them… 
there’s less smell, there’s no ash, it’s cleaner. (Sanjay, 43, current 
IQOS user, less than monthly smoking)
Reports of less positive sensory experiences were limited to 
not liking the taste of HEETS and noticing an unpleasant smell 
when IQOS started to heat. Indeed, some described that when 
they inserted HEETS into the holder and turned it on, it smelt 
‘burnt’ or like ‘sewage’, ‘a fart’ or ‘manure’. These experiences 
did not deter initial use of IQOS but sometimes discouraged 
ongoing use.
Practical factors
Accessibility
Until availability of HEETS expanded, early users noted that 
purchasing HEETS from an IQOS store was inconvenient; some-
times impeding use. Similarly, variable availability and reduced 
availability outside of London interfered with IQOS use when 
visiting other cities or when travelling overseas. When faced 
with issues of availability, participants temporarily discontinued 
IQOS and smoked combustible cigarettes instead.
It’s not accessible everywhere yet. So that… leads you to… buying 
a cigarette packet anyway, because the area that you’re hanging 
around might not have HEETS. (Yusuf, 25, current IQOS user, 
weekly smoking)
Although some praised the availability of HEETS online, 
they noted that bulk purchasing cartons of HEETS encouraged 
ongoing IQOS use and deterred stopping.
Use in private and public places
Commonly, participants were encouraged to continue using 
IQOS as they could use it in places where they would not smoke. 
Prompted by the reduced smell and appearance of emissions, 
participants used IQOS in their homes and cars. Confident 
that they would be undetected, they also used IQOS in public 
places where smoking and vaping were prohibited, including 
trains, non- office workplaces, pubs, restaurants, the grounds of 
a psychiatric hospital and at boarding school. While beneficial 
on the one hand, participants sometimes disliked that they used 
HEETS more than combustible cigarettes and as a result, they 
had less incentive to quit.
I’m totally conscious because I can smoke in more places, I 
probably do… I certainly have twice the number of HEETS as 
I used to have cigarettes. (Raj, 43, current IQOS user, former 
smoking)
At the same time, participants expressed uncertainty about 
the rules governing IQOS use in public, relative to smoking and 
vaping.
Maintenance and operation
Participants reported that the need to charge and clean IQOS was 
burdensome and hindered IQOS use, especially if their device 
was faulty or broken. Accordingly, they drew parallels between 
IQOS and e- cigarettes, contrasting them with the simplicity of 
smoking combustible cigarettes.
You can’t use the HEETS in any other way. Whereas with a 
cigarette you just go and ask someone for a cigarette… With the 
HEETS, if that technology fails, you’re lost without it. (Sean, 52, 
current IQOS user, former smoking)
Although having to re- charge the holder in the pocket charger 
between HEETS prevented participants from ‘chain- smoking’ 
with IQOS, it prompted them to smoke combustible cigarettes 
when they wanted to chain- smoke.
Psychological factors
Ritual and routines
Participants were encouraged to continue to use IQOS as it 
mirrored their rituals and routines of smoking combustible ciga-
rettes. They drew parallels between the situations when they 
used IQOS and identified similarities between taking a HEET 
out of the packet, the hand- to- mouth action of using IQOS, the 
amount of puffs/time a HEET lasted and the definitive end point 
of finishing a HEET—all of which they contrasted with using 
e- cigarettes.
I like… that the HEETS kind of simulate a cigarette packet… it’s 
the action of taking out a cigarette, I think behaviourally like it 
definitely has played a role, because I feel like I’m still smoking. 
Whereas with a vape I feel like I’m just inhaling some nice flavour. 
(Karina, 22, current IQOS user, monthly smoking)
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Finally, participants discussed how charging and cleaning 
IQOS led them to develop new habits and rituals. However, 
participants were divided on the extent to which these new prac-
tices helped or hindered continued use of IQOS.
Trailblazing and trendsetting
Some participants first used IQOS as they were attracted to 
the ‘cool’ design and technological appeal. Indeed, individuals 
recalled their enjoyment of being an ‘early adopter’ or ‘first 
mover’ when few others in the UK knew of or used IQOS. Using 
IQOS, participants felt ‘trendy’, ‘futuristic’ and at the forefront 
of technological developments in smoking—perceptions that 
were reinforced when others complimented them on IQOS and 
when they visited ‘high- end’, ‘Apple- like’ IQOS stores. Accord-
ingly, the ‘status symbol’ of IQOS, and the more ‘exclusive’ 
experience it offered, differed from combustible cigarettes and 
e- cigarettes and inspired participants to pursue IQOS.
They buy it because it’s cool and looks nice. Honestly no one cares 
that its less hurtful or whatever, it’s just like the new thing. (Sofia, 
20, ex- IQOS user, daily smoking)
In opposition, other participants shared worries about the 
newness of IQOS. They raised anxieties that IQOS may not 
have been sufficiently tested, questioned whether IQOS fit 
with their image, worried about attracting unwanted attention 
and feared the reactions of others. Participants explained that 
these concerns stemmed from their mistrust of PMI and fears of 
having fallen ‘victim’ to their advertising. Although such views 
led participants to question their use of IQOS, they continued 
using IQOS.
social factors
Influence of others
Participants reported that family and friends who used IQOS 
often promoted it to them as an alternative to smoking and urged 
them to try it. Other participants experimented with IQOS to 
appease non- smoking partners, or in response to seeing IQOS 
users in Japan or mainland Europe.
Nevertheless, once participants had switched to IQOS, they 
were sometimes tempted to smoke combustible cigarettes when 
among cigarette smokers.
I buy them (combustible cigarettes)… when I go party and 
especially with friends who smoke… It’s more of a social thing… 
to build the rapport with the person I think it’s easier to follow 
the lead they are doing, instead of trying to break it. (Alexei, 27, 
current IQOS user, monthly smoking)
Acceptability
Participants discussed several social consequences of using IQOS 
which encouraged their ongoing use. First, on account of the 
reduced visibility, amount, smell and perceived harm of the 
emissions, participants said that IQOS was ‘better’ to use around 
non- smokers than combustible cigarettes or e- cigarettes.
[I] feel less guilty smoking the IQOS around other people because… 
as far as I know it’s not as harmful to secondhand smokers as 
cigarettes. (Yasmina, 25, current IQOS user, weekly smoking)
Furthermore, as using IQOS attracted little attention, partic-
ipants felt more comfortable using it in public or when in the 
company of non- smokers. Participants felt less ‘vilified’ and 
experienced less stigma and negative judgement with IQOS than 
when they had smoked or vaped.
It’s satisfying socially… I don’t have to exclude myself from 
any conversations… anymore… because when I was smoking, I 
really felt uncomfortable standing with people who didn’t smoke, 
because that smoke is quite unpleasant. (Sean, 52, current IQOS 
user, former smoking)
Others attributed improvements in relationships with romantic 
partners and work colleagues to the absence of cigarette smoke 
on their breath, hair, and clothes.
Meanwhile, participants also criticised IQOS for limiting 
shared social experiences with other smokers. For example, 
users did not pass and share HEETS or IQOS in the same way 
as combustible cigarettes and they missed spontaneous conversa-
tions sparked by borrowing a lighter. Furthermore, IQOS users 
occasionally worried about being judged by cigarette smokers 
due to perceptions that IQOS was only affordable to the 
wealthier middle classes. These experiences discouraged them 
from using IQOS in situations where they did not want to be 
seen as ‘different’ or where they wanted to bond with cigarette 
smokers.
It’s not as social an experience as smoking… because no one uses 
IQOS and there’s only one, one device… (with cigarettes) you can 
pass around your packet, say, ‘have one of these’. You can’t do that 
with IQOS… so it didn’t feel like there was that shared moment 
that you have when you smoke with friends. (Peter, 39, ex- IQOS 
user, daily smoking)
dIsCussIon
As far as we are aware, this is the first independent qualitative 
study of IQOS users/ex- users outside of Japan and Switzerland, 
and the first to use in- depth one- to- one interviews.28 29 Similar 
to previous studies, initiation was encouraged by novelty and the 
sleek appearance of IQOS.29 Participants commonly used IQOS 
to reduce the harms of smoking, also reflecting earlier findings.28 
Perceptions of reduced harm relative to smoking were under-
pinned by messages that IQOS emits 95% less chemicals than 
cigarettes, and were reinforced by the cleanliness of using IQOS, 
the lighter sensory perceptions, the simple branding of HEETS 
packets with a text- only warning and the lack of pictorial health 
warnings. Optimism helped maintain the belief that IQOS was 
less harmful than smoking, yet participants understood that 
IQOS was not risk- free. Visual and sensory similarities between 
HEETS and combustible cigarettes also encouraged continued 
use, along with the lack of smoke and lingering smell. Yet, the 
lack of smell also reduced thoughts about stopping IQOS, in 
contrast to how the lingering smell of combustible cigarette 
smoke sometimes served as a reminder to quit.
The high initial start- up cost was a barrier to trying IQOS, 
while the cheaper price of HEETS compared with combustible 
cigarettes (but not rolling tobacco or e- cigarettes) encouraged 
continued use. Perceived physical health improvements contrib-
uted to continued use, whereas reduced satisfaction deterred 
continued use. Practical factors, such as availability of HEETS, 
and wanting to bond in social interactions with cigarette smokers 
discouraged some situational use but not overall use.
No single factor above all else was important for IQOS use. 
For example, despite the importance of reduced harm, partic-
ipants explained that if IQOS turned out be equally or more 
harmful than combustible cigarettes, they would likely still use 
IQOS due to other perceived benefits. Furthermore, various 
factors interacted with one another and influenced use. For 
example, the ability to use IQOS in more places combined with 
perceptions of reduced harm led some participants to use more 
HEETS than combustible cigarettes, despite initial intentions 
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What this paper adds
What is already known on this subject
 ► Smokers in Japan and Switzerland appear to be taking up 
IQOS use due to several reasons, including lower perceived 
harm and cleanliness.
What important gaps in knowledge exist on this topic
 ► Outside of Japan and Switzerland, independent consumer 
research on IQOS is mostly non- existent, particularly in 
countries such as the UK where strong tobacco control 
policies exist and the e- cigarette market is well established.
What this paper adds
 ► UK smokers and ex- smokers endorsed similar reasons for 
using IQOS as those in Switzerland and Japan, particularly 
reduced harm, smell and cleanliness. Perceptions of harm 
reduction were underpinned by industry pronouncements, 
the non- combustible process involved, and the appearance 
of IQOS- related packaging and labelling. Some advantages 
of IQOS over e- cigarettes were reported such as reduced 
emissions, smell, and clear start and end point of a bout of 
use.
to reduce smoking behaviours. In addition, even though prac-
tical challenges such as charging deterred use, the same finding 
emerged in our early qualitative e- cigarette research.32 It is 
worth noting that e- cigarette users/the market adapted to meet 
these challenges, and IQOS users/manufacturers will likely do 
the same.
Many of the influences on IQOS use were similar to those 
identified in e- cigarette research—harm reduction encouraged 
use32 whereas practical factors discouraged use.33 However, 
unlike previous studies, participants described the reasons that 
they used IQOS by comparing the benefits of IQOS with the 
perceived drawbacks of e- cigarettes. Compared with e- ciga-
rettes, IQOS smelt better, was less bulky, felt more like combus-
tible cigarettes in the hands and mouth, and HEETS had an end 
point.
Policy and research implications
Our findings on how reduced harm perceptions, the packaging, 
price and indoor use of IQOS influenced use have important 
policy and research implications. Research on how tobacco/
nicotine policies, such as health warnings and taxation/price, and 
industry behaviour interact to influence switching from combus-
tible cigarettes to IQOS is needed. The finding that some partici-
pants used up to twice as many HEETS as combustible cigarettes 
warrants follow- up considering a study comparing HTP and 
combustible cigarette costs34 assumed that people smoked equal 
numbers of combustible cigarettes and heated tobacco sticks. 
As current smoke- free policies in the UK do not officially cover 
IQOS, the ability to use IQOS undetected also warrants further 
research, as does research into the content of IQOS emissions 
and potential harms to bystanders. Given that the FDA has now 
authorised IQOS for the US market, our findings may also help 
inform research into US policy options.
As our study took place in London, our findings may not be 
generalisable. Yet, many of our findings aligned with studies of 
IQOS users in Switzerland and Japan,28 29 suggesting that they 
will likely be applicable to other contexts. Given most partici-
pants were currently using IQOS, our findings may reflect more 
positive experiences of use. Although reasons behind individuals’ 
discontinuation of IQOS was uncovered, additional explanations 
may exist given our small sample of ex- users. In addition, as 
most of the sample had negative experiences of e- cigarettes, we 
cannot speculate how those with more positive experiences of 
e- cigarette use may experience IQOS. Lastly, although the team 
regularly discussed the coding process, having a single coder 
could be criticised for potential bias.
Nevertheless, this is the first independent qualitative interview 
study of IQOS, which was deliberately informed by consulta-
tions with experts and smokers/ex- smokers to prioritise key 
areas of research and policy relevance, and used multiple recruit-
ment methods to access a diverse sample with a range of views 
and experiences.
ConClusIon
Overall, this study found that a variety of factors influenced 
IQOS initiation and continued use. The perceived drawbacks of 
IQOS and the continuing appeal of combustible cigarettes led 
some people to stop using IQOS altogether, and others to stop 
situational use of IQOS, smoking combustible cigarettes instead. 
Several factors that encouraged/discouraged IQOS use may be 
considered by regulators if they wish to influence use, including 
packaging, labelling, risk communication, taxation and smoke- 
free policies.
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